AU2003266210A1 - Use of mas-compounds for treating diseases associated with lipid metabolism - Google Patents

Use of mas-compounds for treating diseases associated with lipid metabolism

Info

Publication number: AU2003266210A1
Authority: AU; Australia
Prior art keywords: mas; compounds; diseases associated; treating diseases; lipid metabolism
Prior art date: 2002-09-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003266210A

Other versions

AU2003266210A8 (en

Inventor

Christian Grondahl

Bernhard Lindenthal

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer Pharma AG

Novo Nordisk AS

Original Assignee

Novo Nordisk AS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-25

Filing date

2003-09-23

Publication date

2004-04-19

2003-09-23 Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS

2004-04-19 Publication of AU2003266210A8 publication Critical patent/AU2003266210A8/en

2004-04-19 Publication of AU2003266210A1 publication Critical patent/AU2003266210A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

AU2003266210A 2002-09-25 2003-09-23 Use of mas-compounds for treating diseases associated with lipid metabolism Abandoned AU2003266210A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DKPA200201417		2002-09-25
DKPA200201417		2002-09-25
PCT/DK2003/000619 WO2004028544A1 (en)	2002-09-25	2003-09-23	Use of mas-compounds for treating diseases associated with lipid metabolism

Publications (2)

Publication Number	Publication Date
AU2003266210A8 AU2003266210A8 (en)	2004-04-19
AU2003266210A1 true AU2003266210A1 (en)	2004-04-19

Family

ID=32039048

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003266210A Abandoned AU2003266210A1 (en)	2002-09-25	2003-09-23	Use of mas-compounds for treating diseases associated with lipid metabolism

Country Status (2)

Country	Link
AU (1)	AU2003266210A1 (en)
WO (1)	WO2004028544A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5697296B2 (en)	2004-03-05	2015-04-08	ザトラスティーズオブザユニバーシティオブペンシルバニア	Method for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia with minimal side effects
CN116322682A (en)	2020-07-29	2023-06-23	艾米琳制药有限责任公司	Lomitapide for use in a method of treating hyperlipidemia and hypercholesterolemia in a pediatric patient
CN116509877B (en) *	2023-04-26	2025-02-28	复旦大学附属肿瘤医院	Application of a compound T-MAS in the preparation of drugs for treating breast cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5506354A (en) *	1985-09-12	1996-04-09	The Upjohn Company	Imidazolylpiperazinyl steroids
US4939134A (en) *	1988-09-19	1990-07-03	New York University	26-aminocholesterol and derivatives and analogs thereof in the regulation of cholesterol accumulation in body tissue
JPH0491026A (en) *	1990-08-06	1992-03-24	Green Cross Corp:The	Fat emulsion containing vegetable sterol

2003
- 2003-09-23 WO PCT/DK2003/000619 patent/WO2004028544A1/en not_active Ceased
- 2003-09-23 AU AU2003266210A patent/AU2003266210A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004028544A1 (en)	2004-04-08
AU2003266210A8 (en)	2004-04-19

Similar Documents

Publication	Publication Date	Title
AU2003239568A1 (en)	2003-12-12	Pyrrolotriazinone compounds and their use to treat diseases
PL374725A1 (en)	2005-10-31	Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
AU2003279338A1 (en)	2004-05-25	Phenethanolamine derivatives for the treatment of respiratory diseases
AU2003286567A1 (en)	2004-05-13	Methods for the treatment of skin disorders
AU2003286728A1 (en)	2004-06-07	Compounds for the treatment of metabolic disorders
ZA200707934B (en)	2009-03-25	Thereapeutic formulations for the treatment of beta-amyloid related diseases
AUPS160602A0 (en)	2002-05-16	Therapeutic method
AU2003223684A1 (en)	2003-11-10	Lxr modulators for the treatment of cardiovascular diseases
AU2003290939A1 (en)	2004-06-15	Replication of biological tiussue
AU2003240545A1 (en)	2003-12-22	Use of ramoplanin to treat diseases associated with the use of antibiotics
AU2003230004A1 (en)	2003-11-11	Methods of therapy for inducing tolerance
AU2003266210A1 (en)	2004-04-19	Use of mas-compounds for treating diseases associated with lipid metabolism
AU2003262264A1 (en)	2004-03-11	Agent for reducing side effects of diclofenac
AU2003295504A1 (en)	2004-06-07	Development of therapeutics for the treatment of endotoxin-mediated diseases
AU2002364889A1 (en)	2003-06-10	Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
AU2003232844A1 (en)	2003-12-12	Morpholin-acetamide derivatives for the treatment of inflammatory diseases
AU2003279461A1 (en)	2004-06-07	Disorders of lipid metabolism
AU2003293581A1 (en)	2004-07-22	Method of identifying therapeutic agents
HK40032312A (en)	2021-03-26	Administration of agents for the treatment of inflammation
AU2003231937A1 (en)	2003-12-19	Therapeutic methods
AU2003297570A1 (en)	2004-06-18	Treatment of skin diseases
AU2002357964A1 (en)	2003-07-09	Use of coagulant-active antitrhombin iii for the therapy of angiogenesis-dependent diseases
AU2003213349A1 (en)	2003-09-22	Therapeutic agent for pain
AU2003296060A1 (en)	2004-07-29	Ophthalmic therapeutic composition
AU2003244633A1 (en)	2004-01-23	Methods for the treatment of sinusitis

Legal Events

Date	Code	Title	Description
2005-06-16	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase